Adalank (N-Acetyl Selank Amidate)
N-Acetyl Selank Amidate | Enhanced Tuftsin Analog
Community Research
Join others researching Adalank — share findings, ask questions, and learn from real experiences
Enhanced derivative of Selank with improved stability, blood-brain barrier penetration, and extended half-life compared to parent compound. Parent compound Selank approved in Russia since early 2000s.
Modulates GABAergic neurotransmission, upregulates hippocampal BDNF, influences serotonin metabolism, and provides immunomodulatory effects without benzodiazepine-like dependency.
Molecular Data
?TKPRPGP?Ac
Position 1
Threonine
Position 2
Lysine
Position 3
Proline
Position 4
Arginine
Position 5
Proline
Position 6
Glycine
Position 7
Proline
Position 8
NH2
Position 9
Research Indications
Clinical trials showed effects comparable to benzodiazepines; 40% rapid response within 1-3 days.
Reduces stress hormones and balances neurotransmitters without sedation.
Unlike benzodiazepines, provides relief without tolerance, withdrawal, or dependency.
Improves focus, attention, and mental clarity.
BDNF-mediated neuroplasticity supports memory formation.
Rapidly elevates BDNF expression, supporting neuronal survival.
Enhances ability to cope with psychological stress.
Dosing Protocols
Subcutaneous injection to belly, thigh, or upper arm. Morning administration aligns with cortisol rhythms.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Anxiety Reduction | 200-300mcg | 1x daily (morning) | SubQ |
| Cognitive Enhancement | 200-500mcg | 1x daily | SubQ |
| Stress Management | 200-300mcg | 2x daily (morning, afternoon) | SubQ |
| Initial Trial | 100-200mcg | 1x daily | SubQ |
Reconstitution Instructions
- Bacteriostatic water (BAC)
- Insulin syringes
- Alcohol swabs
- Sterile work surface
- 1 Clean work area thoroughly
- 2 Calculate BAC water volume
- 3 Draw water into syringe
- 4 Inject slowly down vial side (not directly onto powder)
- 5 Gently swirl until dissolved (never shake vigorously)
- 6 Store at 2-8°C
- 7 Use within 14-30 days
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Parent compound has high safety profile in Russian clinical research
- Minimal side effects reported
Stop Signs - Discontinue if:
- Unusual or persistent headaches
- Significant mood changes or depression
- Unexpected sedation or extreme fatigue
- Unusual neurological symptoms
- Persistent injection site reactions or nasal irritation
- Severe gastrointestinal distress
Contraindications
- Experimental peptide with limited direct human research on N-Acetyl form
- Not recommended during pregnancy or breastfeeding
- Consult healthcare provider before use with psychiatric medications
Quality Checklist
Good Signs
- White, fluffy powder; proper freeze-drying indicated
- Clear solution after reconstitution; no particles or cloudiness
- Proper labeling with peptide name, batch number, manufacturing date
Warning Signs
- Slight compaction from shipping acceptable if powder dissolves with gentle swirling
Bad Signs
- Discoloration or yellowing indicates oxidation or degradation
- Persistent cloudiness or particles indicate degraded or contaminated peptide
References
- Selank for GAD - Non-inferiority Trial(N/A)
62 patients with GAD; 2700mcg/day intranasal; 14 days. Anxiolytic effects comparable to medazepam; 40% rapid response within 1-3 days.
- Selank and BDNF Regulation in Hippocampus(N/A)
Rat study; intranasal administration. Rapidly elevated BDNF expression, confirming neurotrophin involvement.
- Peptide Selank Enhances Diazepam Effects(N/A)
Rats in chronic mild stress model. Enhanced anxiolytic effects while reducing memory impairment and sedation.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.